BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12072421)

  • 1. Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer.
    Kagei K; Hosokawa M; Shirato H; Kusumi T; Shimizu Y; Watanabe A; Ueda M
    Jpn J Clin Oncol; 2002 Apr; 32(4):120-7. PubMed ID: 12072421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome.
    Lee JS; Ahn JY; Choi KD; Song HJ; Kim YH; Lee GH; Jung HY; Ryu JS; Kim SB; Kim JH; Park SI; Cho KJ; Kim JH
    Korean J Intern Med; 2016 Mar; 31(2):253-9. PubMed ID: 26864297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer.
    Wang WL; Wang CP; Wang HP; Lee CT; Chang CY; Tai CM; Tseng CH; Hwang TZ; Wang CC; Lo JL; Tseng PH; Chiu HM; Lee JM; Ko JY; Lou PJ; Wu MS; Lee YC; Lin JT
    Oral Oncol; 2013 Aug; 49(8):808-13. PubMed ID: 23688774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal cancers with synchronous or antecedent head and neck cancers: a more formidable challenge?
    Lo OS; Law S; Wei WI; Ng WM; Wong KH; Tong KH; Wong J
    Ann Surg Oncol; 2008 Jun; 15(6):1750-6. PubMed ID: 18347873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis.
    Mitani S; Kadowaki S; Oze I; Masuishi T; Narita Y; Bando H; Oonishi S; Hirayama Y; Tanaka T; Tajika M; Koide Y; Kodaira T; Abe T; Muro K
    Cancer Med; 2020 Jan; 9(1):394-400. PubMed ID: 31730285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.
    Wang YK; Chuang YS; Wu TS; Lee KW; Wu CW; Wang HC; Kuo CT; Lee CH; Kuo WR; Chen CH; Wu DC; Wu IC
    Int J Cancer; 2017 Nov; 141(10):1987-1996. PubMed ID: 28758200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.
    Kim DH; Gong EJ; Jung HY; Lim H; Ahn JY; Choi KS; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY; Baek S
    Scand J Gastroenterol; 2014 Dec; 49(12):1486-92. PubMed ID: 25372595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Esophageal cancer and multiple primary cancer].
    Makuuchi H; Tanaka H; Shimada H; Chino O; Nishi T; Machimura T; Nakasaki H; Mitomi T
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):1-7. PubMed ID: 9020938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal cancer in patients with head and neck cancers.
    Miyazato H; Tamai O; Tomita S; Shiraishi M; Kusano T; Muto Y; Koja S
    Int Surg; 1997; 82(3):319-21. PubMed ID: 9372384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Staged Treatment Strategy for Patients with Synchronous Double Cancers of the Esophagus and Head and Neck: A Retrospective Study.
    Matsumoto A; Watanabe M; Shigaki H; Nishida K; Mine S; Sano T; Yanaga K
    World J Surg; 2016 Feb; 40(2):388-94. PubMed ID: 26470701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
    Jégu J; Binder-Foucard F; Borel C; Velten M
    Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer.
    Miyazaki T; Sohda M; Higuchi T; Tanaka N; Suzuki S; Sakai M; Yokobori T; Nakajima M; Fukuchi M; Tsushima Y; Kato H; Kuwano H
    Anticancer Res; 2014 Jan; 34(1):283-7. PubMed ID: 24403475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study.
    Gong EJ; Kim DH; Ahn JY; Choi KS; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY
    Dis Esophagus; 2016 Oct; 29(7):752-759. PubMed ID: 26471351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a Preoperative Gastrointestinal Endoscopy for Second Primary Cancer Detection in Head and Neck Cancer Necessary? Ten-year Registry Data.
    Heo GM; Kim MH; Kim JH; Rho YS; Shin WG
    Korean J Gastroenterol; 2016 Jul; 68(1):23-8. PubMed ID: 27443620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer.
    Yamashita T; Araki K; Tomifuji M; Tanaka Y; Harada E; Suzuki T; Miyamoto S; Shiotani A
    Asia Pac J Clin Oncol; 2017 Jun; 13(3):172-178. PubMed ID: 27783469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis was not deteriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy.
    Shirai K; Tamaki Y; Kitamoto Y; Murata K; Satoh Y; Higuchi K; Ishikawa H; Nonaka T; Takahashi T; Nakano T
    J Radiat Res; 2013 Jul; 54(4):706-11. PubMed ID: 23381956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous primary cancers of the head and neck region and upper aero digestive tract: defining high-risk patients.
    Krishnatreya M; Rahman T; Kataki AC; Das A; Das AK; Lahkar K
    Indian J Cancer; 2013; 50(4):322-6. PubMed ID: 24369209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
    Hanamoto A; Takenaka Y; Shimosegawa E; Ymamamoto Y; Yoshii T; Nakahara S; Hatazawa J; Inohara H
    Ann Nucl Med; 2013 Dec; 27(10):880-5. PubMed ID: 23979967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer.
    Chen MC; Huang WC; Chan CH; Chen PT; Lee KD
    Oral Oncol; 2010 Apr; 46(4):249-54. PubMed ID: 20138797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.